“Biopharmaceuticals Manufacturing Consumables Testing Market Report is set to have rapid growth due to technological advancements and changing or improving regulatory requirements for analysis of raw materials required during biologics manufacturing at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Biopharmaceuticals Manufacturing Consumables Testing Market Forecast 2019-2029: By Service (Compendial Testing, Laboratory Testing), By Raw Material Type (Excipients, API), Regions and segmental Forecasts.
Effective and successful biopharmaceutical production largely depends on the purity and quality of consumables used during production. With increasing problems related to the quality of new therapies such as poor solubility, increased molecular size and poor absorption properties, there is an increase in attention in the exploration of the various attributes of excipients and other raw materials.
The rapid growth of the biopharmaceutical industry has made it necessary to keep pace with the change or improvement of regulatory requirements for the analysis of raw materials required during organic production. Consequently, manufacturers of final products require the support of the supplier qualification program to validate whether the services offered by the supplier are in compliance with the complementary monographs. This led the segment to support the supplier qualification program based on compendial methods. In addition, technological advances in analytical technologies have provided suppliers with improved capabilities to test proteins, raw materials, cell lines and other consumables used during the production of large molecules. Advances in portable Raman spectroscopy methods are one of the significant developments in this market. Agilent Technologies is one of the companies that offers products based on the principle of Raman spectroscopy.
Leading companies featured in the report include Alcami Corporation; Merck KGaA; Eurofins Scientific; Agilent Technologies; Charles River; Catalent, Inc.; Avomeen Analytical Services; BioSpectra; Pace Analytical Services, LLC and Gibraltar Laboratories
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global wound care market is big, and only set to grow bigger. Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024. The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …
30 March 2020
Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.
30 March 2020
New technologies will be needed to ensure that scaling-up of manufacturing operations can be done effectively once stem cell treatments enter the market.
24 March 2020
As per the latest reports of UNCTAD (United Nations Conference on Trade and Development), COVID-19 pandemic has not only led to tragic human consequences but is projected to cost the global economy $1 trillion in 2020.